Breaking News, Promotions & Moves

Heat Biologics Appoints Head of R&D

Schreiber brings expertise the field of tumor immunology

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Taylor H. Schreiber, M.D., Ph.D., has been appointed vice president of R&D at Heat Biologics, Inc. to lead the company’s ImPACT Therapy preclinical drug development research team.   Dr. Schreiber brings expertise the field of tumor immunology and is co-inventor of significant elements of Heat’s ImPACT Technology platform. He has more than 10 years of lab experience and skills in the discovery of therapeutic immuno-oncology compounds. Dr. Schreiber is also a co-inventor of TNFRSF2...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters